<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(24)</volume><submitter>Han D</submitter><pubmed_abstract>&lt;b>Rationale:&lt;/b> Cell therapy for myocardial infarction is promising but largely unsuccessful in part due to a lack of mechanistic understanding. Techniques enabling identification of stem cell-specific proteomes &lt;i>in situ&lt;/i> in the injured heart may shed light on how the administered cells respond to the injured microenvironment and exert reparative effects. &lt;b>Objective:&lt;/b> To identify the proteomes of the transplanted mesenchymal stem cells (MSCs) in the infarcted myocardium, we sought to target a mutant methionyl-tRNA synthetase (MetRS&lt;sup>L274G&lt;/sup>) in MSCs, which charges azidonorleucine (ANL), a methionine analogue and non-canonical amino acid, to tRNA and subsequently to nascent proteins, permitting isolation of ANL-labeled MSC proteomes from ischemic hearts by ANL-alkyne base</pubmed_abstract><journal>Theranostics</journal><pagination>11324-11338</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7532665</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Analysis of mesenchymal stem cell proteomes &lt;i>in situ&lt;/i> in the ischemic heart.</pubmed_title><pmcid>PMC7532665</pmcid><pubmed_authors>Mobley J</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Zhang E</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Lu D</pubmed_authors><pubmed_authors>Qiao A</pubmed_authors><pubmed_authors>Luo B</pubmed_authors><pubmed_authors>Jie C</pubmed_authors><pubmed_authors>Yan W</pubmed_authors><pubmed_authors>Boriboun C</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Xu S</pubmed_authors><pubmed_authors>Qin G</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors><pubmed_authors>Han D</pubmed_authors><pubmed_authors>Sun J</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Analysis of mesenchymal stem cell proteomes &lt;i>in situ&lt;/i> in the ischemic heart.</name><description>&lt;b>Rationale:&lt;/b> Cell therapy for myocardial infarction is promising but largely unsuccessful in part due to a lack of mechanistic understanding. Techniques enabling identification of stem cell-specific proteomes &lt;i>in situ&lt;/i> in the injured heart may shed light on how the administered cells respond to the injured microenvironment and exert reparative effects. &lt;b>Objective:&lt;/b> To identify the proteomes of the transplanted mesenchymal stem cells (MSCs) in the infarcted myocardium, we sought to target a mutant methionyl-tRNA synthetase (MetRS&lt;sup>L274G&lt;/sup>) in MSCs, which charges azidonorleucine (ANL), a methionine analogue and non-canonical amino acid, to tRNA and subsequently to nascent proteins, permitting isolation of ANL-labeled MSC proteomes from ischemic hearts by ANL-alkyne base</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-05T12:52:29.017Z</modification><creation>2020-10-29T09:20:18Z</creation></dates><accession>S-EPMC7532665</accession><cross_references><pubmed>33042285</pubmed><doi>10.7150/thno.47893</doi></cross_references></HashMap>